Results 211 to 220 of about 60,784 (262)

Efectos nucleares del receptor Tirosina Quinasa ErbB-2 en cáncer de mama

, 2017
Patricia V. Elizalde, Rosalía I. Cordo Russo, María F. Chervo, Cecilia Jazmín Proietti Anastasi, Roxana Schillaci, Eduardo H. Charreau   +5 more
openalex   +1 more source

Immunohistochemical study on expression of C-MYC, P53, C-ERBB-2 and epidermal growth factor receptor in human thyroid tumors.

, 1991
Kenji Kashima, Shigeo Yokoyama, Iwao Nakayama, Shiro Noguchi   +3 more
openalex   +2 more sources

EGFR activation in cholangiocytes promotes extrahepatic bile duct regeneration after injury. [PDF]

Hepatol Commun
Calder AN, Sakaguchi T, Peter M, Tobias J, Frankel T, Razumilava N.   +5 more
europepmc   +1 more source

Taking the 'low' into consideration: Discussions on redefining HER2 status in breast cancer (Review). [PDF]

Mol Clin Oncol
Georgiou A, Spiteri EA, Spandidos DA, Agelaki S, Zoumpourlis V.   +4 more
europepmc   +1 more source

MMP‐9 controls Schwann cell proliferation and phenotypic remodeling via IGF‐1 and ErbB receptor‐mediated activation of MEK/ERK pathway

, 2009
Sharmila Chattopadhyay, Veronica I. Shubayev   +1 more
openalex   +1 more source

Pan-ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal Cancer. [PDF]

United European Gastroenterol J
Buchloh J, Spitzner M, Zimmermann H, Fang X, Tapia Contreras C, Schneider C, de Oliveria T, Küffer S, Linnebacher M, Rühlmann F, Conradi L, Wirth M, Ghadimi M, Grade M, Gaedcke J, Schneider G.   +15 more
europepmc   +1 more source

Targeting ERBB receptors shifts their partners and triggers persistent ERK signaling through a novel ERBB/EFNB1 complex. [PDF]

Cancer Res, 2013
Vermeer PD, Colbert PL, Wieking BG, Vermeer DW, Lee JH.   +4 more
europepmc   +1 more source

Molecular Crosstalk and Therapeutic Synergy: Tyrosine Kinase Inhibitors and Cannabidiol in Oral Cancer Treatment. [PDF]

Curr Issues Mol Biol
AlRaheem ZSG, Le TT, Seyfoddin A, Li Y.
europepmc   +1 more source

Novel Humanized Anti-HER3 Antibodies: Structural Characterization and Therapeutic Activity. [PDF]

Antibodies (Basel)
Muzi A, Arriga R, Bulfaro G, Fata F, Costanzo A, Chiarini V, Cappelletti M, Ferrara FF, Bucci F, Montemiglio LC, Savino C, Marra E, Ciliberto G, Aurisicchio L, Vallone B, Roscilli G.   +15 more
europepmc   +1 more source

Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancer. [PDF]

Mol Syst Biol
Griffiths JI, Chi F, Farmaki E, Medina EF, Cosgrove PA, Karimi KL, Chen J, Grolmusz VK, Adler FR, Khan QJ, Nath A, Chang JT, Bild AH.   +12 more
europepmc   +1 more source